Simon Cauchemez

InstitutionMathematical Modelling of Infectious Diseases Unit
AddressParis
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 21 Covid-19 publications, with a maximum of 5 publications in July 2021
    All Publications
    Bar chart showing 111 publications over 17 distinct years, with a maximum of 15 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cauchemez S, Kiem CT. Managing COVID-19 importation risks in a heterogeneous world. Lancet Public Health. 2021 09; 6(9):e626-e627. PMID: 34388388.
      Citations: 2     Fields:    Translation:Humans
    2. Kraemer MUG, Hill V, Ruis C, Dellicour S, Bajaj S, McCrone JT, Baele G, Parag KV, Battle AL, Gutierrez B, Jackson B, Colquhoun R, O'Toole Á, Klein B, Vespignani A, Volz E, Faria NR, Aanensen DM, Loman NJ, du Plessis L, Cauchemez S, Rambaut A, Scarpino SV, Pybus OG. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence. Science. 2021 08 20; 373(6557):889-895. PMID: 34301854.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    3. Cauchemez S, Bosetti P, Kiem CT, Mouro V, Consoli A, Fontanet A. Education and mental health: good reasons to vaccinate children. Lancet. 2021 07 31; 398(10298):387. PMID: 34273293.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    4. Tran Kiem C, Massonnaud CR, Levy-Bruhl D, Poletto C, Colizza V, Bosetti P, Fontanet A, Gabet A, Olié V, Zanetti L, Boëlle PY, Crépey P, Cauchemez S. A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures. EClinicalMedicine. 2021 Aug; 38:101001. PMID: 34278284.
      Citations: 8     
    5. Charmet T, Schaeffer L, Grant R, Galmiche S, Chény O, Von Platen C, Maurizot A, Rogoff A, Omar F, David C, Septfons A, Cauchemez S, Gaymard A, Lina B, Lefrancois LH, Enouf V, van der Werf S, Mailles A, Levy-Bruhl D, Carrat F, Fontanet A. Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France. Lancet Reg Health Eur. 2021 Sep; 8:100171. PMID: 34278372.
      Citations: 5     
    6. Tran Kiem C, Andronico A, Bosetti P, Paireau J, Alter L, Boëlle PY, Fontanet A, Lévy-Bruhl D, Cauchemez S. Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021. Euro Surveill. 2021 07; 26(26). PMID: 34212840.
      Citations: 2     Fields:    Translation:Humans
    7. Landier J, Paireau J, Rebaudet S, Legendre E, Lehot L, Fontanet A, Cauchemez S, Gaudart J. Cold and dry winter conditions are associated with greater SARS-CoV-2 transmission at regional level in western countries during the first epidemic wave. Sci Rep. 2021 06 17; 11(1):12756. PMID: 34140557.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    8. Galmiche S, Charmet T, Schaeffer L, Paireau J, Grant R, Chény O, Von Platen C, Maurizot A, Blanc C, Dinis A, Martin S, Omar F, David C, Septfons A, Cauchemez S, Carrat F, Mailles A, Levy-Bruhl D, Fontanet A. Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study. Lancet Reg Health Eur. 2021 Aug; 7:100148. PMID: 34124709.
      Citations: 6     
    9. Tran Kiem C, Crépey P, Bosetti P, Levy Bruhl D, Yazdanpanah Y, Salje H, Boëlle PY, Cauchemez S. Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study. Euro Surveill. 2021 06; 26(22). PMID: 34085634.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    10. Hozé N, Paireau J, Lapidus N, Tran Kiem C, Salje H, Severi G, Touvier M, Zins M, de Lamballerie X, Lévy-Bruhl D, Carrat F, Cauchemez S. Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study. Lancet Public Health. 2021 06; 6(6):e408-e415. PMID: 33838700.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    11. Lefrancq N, Paireau J, Hozé N, Courtejoie N, Yazdanpanah Y, Bouadma L, Boëlle PY, Chereau F, Salje H, Cauchemez S. Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis. Lancet Reg Health Eur. 2021 Jun; 5:100087. PMID: 34104903.
      Citations: 3     
    12. Andronico A, Tran Kiem C, Paireau J, Succo T, Bosetti P, Lefrancq N, Nacher M, Djossou F, Sanna A, Flamand C, Salje H, Rousseau C, Cauchemez S. Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana. Nat Commun. 2021 03 12; 12(1):1634. PMID: 33712596.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    13. Gaymard A, Bosetti P, Feri A, Destras G, Enouf V, Andronico A, Burrel S, Behillil S, Sauvage C, Bal A, Morfin F, Van Der Werf S, Josset L, Blanquart F, Coignard B, Cauchemez S, Lina B. Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021. Euro Surveill. 2021 03; 26(9). PMID: 33663644.
      Citations: 19     Fields:    Translation:Humans
    14. Lapidus N, Paireau J, Levy-Bruhl D, de Lamballerie X, Severi G, Touvier M, Zins M, Cauchemez S, Carrat F. Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population. Infect Dis Now. 2021 Jun; 51(4):380-382. PMID: 33521775.
      Citations: 5     Translation:Humans
    15. Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S. Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France. Euro Surveill. 2021 01; 26(1). PMID: 33413741.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    16. O'Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021 02; 590(7844):140-145. PMID: 33137809.
      Citations: 174     Fields:    Translation:HumansPHPublic Health
    17. Fontanet A, Cauchemez S. COVID-19 herd immunity: where are we? Nat Rev Immunol. 2020 10; 20(10):583-584. PMID: 32908300.
      Citations: 129     Fields:    Translation:HumansCellsPHPublic Health
    18. Cauchemez S, Kiem CT, Paireau J, Rolland P, Fontanet A. Lockdown impact on COVID-19 epidemics in regions across metropolitan France. Lancet. 2020 10 10; 396(10257):1068-1069. PMID: 33007219.
      Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
    19. Adam DC, Wu P, Wong JY, Lau EHY, Tsang TK, Cauchemez S, Leung GM, Cowling BJ. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat Med. 2020 11; 26(11):1714-1719. PMID: 32943787.
      Citations: 137     Fields:    Translation:HumansPHPublic Health
    20. Du Z, Wang L, Cauchemez S, Xu X, Wang X, Cowling BJ, Meyers LA. Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China. Emerg Infect Dis. 2020 05; 26(5):1049-1052. PMID: 32053479.
      Citations: 135     Fields:    Translation:HumansCellsPHPublic Health
    21. Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, Andronico A, Hozé N, Richet J, Dubost CL, Le Strat Y, Lessler J, Levy-Bruhl D, Fontanet A, Opatowski L, Boelle PY, Cauchemez S. Estimating the burden of SARS-CoV-2 in France. Science. 2020 07 10; 369(6500):208-211. PMID: 32404476.
      Citations: 340     Fields:    Translation:HumansCellsPHPublic Health
    22. Donnelly CA, Malik MR, Elkholy A, Cauchemez S, Van Kerkhove MD. Worldwide Reduction in MERS Cases and Deaths since 2016. Emerg Infect Dis. 2019 09; 25(9):1758-1760. PMID: 31264567.
      Citations: 28     Fields:    Translation:HumansPHPublic Health
    23. Bernard-Stoecklin S, Nikolay B, Assiri A, Bin Saeed AA, Ben Embarek PK, El Bushra H, Ki M, Malik MR, Fontanet A, Cauchemez S, Van Kerkhove MD. Comparative Analysis of Eleven Healthcare-Associated Outbreaks of Middle East Respiratory Syndrome Coronavirus (Mers-Cov) from 2015 to 2017. Sci Rep. 2019 05 14; 9(1):7385. PMID: 31089148.
      Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
    24. Cauchemez S, Nouvellet P, Cori A, Jombart T, Garske T, Clapham H, Moore S, Mills HL, Salje H, Collins C, Rodriquez-Barraquer I, Riley S, Truelove S, Algarni H, Alhakeem R, AlHarbi K, Turkistani A, Aguas RJ, Cummings DA, Van Kerkhove MD, Donnelly CA, Lessler J, Fraser C, Al-Barrak A, Ferguson NM. Unraveling the drivers of MERS-CoV transmission. Proc Natl Acad Sci U S A. 2016 08 09; 113(32):9081-6. PMID: 27457935.
      Citations: 38     Fields:    Translation:HumansAnimals
    25. Lessler J, Salje H, Van Kerkhove MD, Ferguson NM, Cauchemez S, Rodriquez-Barraquer I, Hakeem R, Jombart T, Aguas R, Al-Barrak A, Cummings DA. Estimating the Severity and Subclinical Burden of Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Saudi Arabia. Am J Epidemiol. 2016 Apr 01; 183(7):657-63. PMID: 26851269.
      Citations: 18     Fields:    Translation:HumansCells
    26. Jombart T, Cori A, Didelot X, Cauchemez S, Fraser C, Ferguson N. Bayesian reconstruction of disease outbreaks by combining epidemiologic and genomic data. PLoS Comput Biol. 2014 Jan; 10(1):e1003457. PMID: 24465202.
      Citations: 81     Fields:    Translation:HumansCellsPHPublic Health
    27. Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, Enouf V, van der Werf S, Ferguson NM. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014 Jan; 14(1):50-56. PMID: 24239323.
      Citations: 145     Fields:    Translation:HumansCellsPHPublic Health
    28. Cauchemez S, Van Kerkhove MD, Riley S, Donnelly CA, Fraser C, Ferguson NM. Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill. 2013 Jun 13; 18(24). PMID: 23787162.
      Citations: 66     Fields:    Translation:HumansCellsPHPublic Health
    Cauchemez's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (209)
    Explore
    _
    Co-Authors (156)
    Explore
    _
    Similar People (60)
    Explore
    _